Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

L-Carnitine and Reduced Low-Density Lipoprotein Level

Research synthesisModerate evidenceSmall effect5 studies · 4 beneficial · 1 neutral · 0 harmful

Across 5 studies, 4 reported beneficial small to moderate effects of L-carnitine supplementation on reducing LDL levels, with one study showing a neutral effect. Most studies were meta-analyses in clinical populations (e.g., adults with type 2 diabetes, women with PCOS), and the effective dose ranged from 1 g/day to over 2 g/day. The evidence suggests a small but consistent benefit, though study durations were not consistently reported.

  • Effective dose range: 1 g/day to more than 2 g/day
  • Studied populations: adults with type 2 diabetes, women with polycystic ovary syndrome, hemodialysis patients

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. The effect size is small, and clinical significance may be modest.

Generated Jul 12, 2026
Doses used in studies
  • g/day: 1–2 (median 1.5, IQR 1.25–1.75) — 2 studies
5 of 5 papers
Back to top